Readily Diagnostics develops sensitive, specific and rapid diagnostic testing for infectious disease.
Readily Diagnostics has raised €811k across 1 funding round from 1 investor, most recently a round in Aug 2026. Based in Uppsala, Sweden; active in Healthtech. Data as of 28 Aug 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-08-27 | Other |
| €811k |
| Gates Foundation |
| View deal → |
